BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Heart
,
Avian flu virus
,
Rapamycin
,
rs6983267
,
ZBTB7A
,
nitric oxide metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
gip receptors
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Gastric inhibitory polypeptide receptor antagonism suppresses intramuscular adipose tissue accumulat…
Spatiotemporal regulation of GIPR signaling impacts glucose homeostasis as revealed in studies of a …
Regulation of energy metabolism through central GIPR signaling.
Cardiovascular biology of the GIP receptor.
Design of a novel long-acting dual GLP-1/GIP receptor agonist.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist
Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)
Examination of the Postprandial Bone Remodeling in Persons With Reduced GIP-Receptor Activity
GIP Receptor Antagonist Studies in Humans
The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients With Ty…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ